Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ABSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 201.14M
March 31, 2026 125.70M
December 31, 2025 144.29M
September 30, 2025 168.82M
June 30, 2025 133.67M
March 31, 2025 150.06M
December 31, 2024 128.37M
September 30, 2024 142.87M
June 30, 2024 161.75M
March 31, 2024 177.89M
December 31, 2023 113.85M
September 30, 2023 129.51M
Date Value
June 30, 2023 139.65M
March 31, 2023 159.28M
December 31, 2022 179.45M
September 30, 2022 196.33M
June 30, 2022 221.04M
March 31, 2022 249.02M
December 31, 2021 263.08M
September 30, 2021 289.77M
June 30, 2021 109.95M
March 31, 2021 180.76M
December 31, 2020 69.87M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 166.84M
Prime Medicine, Inc. 95.07M
Beam Therapeutics, Inc. 1.153B
Tenax Therapeutics, Inc. 117.98M
Manhattan Scientifics, Inc. --